Nathan Bahary
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 86
- Pancreatic and Hepatic Oncology Research 67
- Colorectal Cancer Treatments and Studies 7
- Cell Biology 19
- Zebrafish Biomedical Research Applications 13
- Co-authors
- Herbert J. Zeh (46 shared papers)Aatur Dilip Singhi (35 shared papers)Leonard Ira Zon (13 shared papers)Amer H. Zureikat (23 shared papers)Melissa Ellen Hogg (22 shared papers)Rudolph L. Leibel (9 shared papers)Brian A. Boone (11 shared papers)Mazen S. Zenati (18 shared papers)
- Journals
- Annals of Surgical Oncology (22 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (7 papers)Journal of Surgical Oncology (5 papers)The American Journal of Surgical Pathology (5 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Nathan Bahary
157 papers receiving 15.9k citations
Nathan Bahary's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 9.5k
- Cancer Research 3.2k
- Cell Biology 1.2k
- Pulmonary and Respiratory Medicine 2.0k
- Immunology 1.3k
Countries citing papers authored by Nathan Bahary
This map shows the geographic impact of Nathan Bahary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Bahary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Bahary more than expected).
Fields of papers citing papers by Nathan Bahary
This network shows the impact of papers produced by Nathan Bahary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Bahary. The network helps show where Nathan Bahary may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Bahary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Hit paper breakdown → | 2013 | 5355 |
| 2 | Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 1559 |
| 3 | Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer Hit paper breakdown → | 2015 | 479 |
| 4 | 1998 | 444 | |
| 5 | HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 410 |
| 6 | Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma Hit paper breakdown → | 2020 | 370 |
| 7 | 2014 | 353 | |
| 8 | 2019 | 265 | |
| 9 | 2015 | 249 | |
| 10 | 2019 | 234 | |
| 11 | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Hit paper breakdown → | 2024 | 229 |
| 12 | 2015 | 203 | |
| 13 | 2016 | 198 | |
| 14 | 2020 | 192 | |
| 15 | 2014 | 161 | |
| 16 | 2013 | 160 | |
| 17 | 2014 | 159 | |
| 18 | 1991 | 146 | |
| 19 | 2003 | 144 | |
| 20 | 2010 | 144 |
About Nathan Bahary
Nathan Bahary is a scholar working on Oncology, Cell Biology, Surgery, Hepatology and Cancer Research, having authored 160 papers that have together received 16.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (67 papers), Zebrafish Biomedical Research Applications (13 papers), Genetic factors in colorectal cancer (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Congenital heart defects research (7 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). The work is most often cited by research in Oncology (9.5k citations), Cancer Research (3.2k citations), Cell Biology (1.2k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Immunology (1.3k citations). Nathan Bahary has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Herbert J. Zeh, Aatur Dilip Singhi, Leonard Ira Zon, Amer H. Zureikat, Melissa Ellen Hogg, Rudolph L. Leibel, Brian A. Boone, Mazen S. Zenati, Jeffrey M. Friedman and Randall E. Brand. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, Annals of Oncology, Journal of Surgical Oncology and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.